MaxCyte, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
MaxCyte, Inc. (MXCT) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$611.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$542.00K.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$69.00K.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.27M.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $29.00K, a 98.13% decline year-over-year.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $531.00K.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$293.00K, a 145.71% decline from fiscal 2023.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $641.00K.
- MaxCyte, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$320.00K, a 113.89% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$542.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$611.00K 10-Q · filed 2026-08-13 | $664.00K derived: sum of 3 quarters · filed 2026-08-13 | $693.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$69.00K 10-Q · filed 2026-05-13 | $1.21M derived: sum of 2 quarters · filed 2026-05-13 | $1.24M derived: sum of 3 quarters · filed 2026-05-13 | $527.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.30M derived: sum of 2 quarters · filed 2026-03-25 | $596.00K derived: sum of 3 quarters · filed 2026-08-13 | $531.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$679.00K derived: sum of 2 quarters · filed 2026-08-13 | -$744.00K 10-Q · filed 2025-11-13 | -$1.26M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$708.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$773.00K 10-Q · filed 2026-08-13 | -$1.29M derived: sum of 3 quarters · filed 2026-08-13 | $256.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$65.00K 10-Q · filed 2026-05-13 | -$583.00K derived: sum of 2 quarters · filed 2026-05-13 | $964.00K derived: sum of 3 quarters · filed 2026-05-13 | $331.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.03M derived: sum of 2 quarters · filed 2026-03-25 | $396.00K derived: sum of 3 quarters · filed 2026-03-25 | -$293.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $914.00K derived: sum of 2 quarters · filed 2025-11-13 | $225.00K 10-Q · filed 2025-11-13 | -$58.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.32M 10-Q · filed 2025-08-06 | -$1.60M derived: sum of 3 quarters · filed 2025-08-06 | $43.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$689.00K 10-Q · filed 2025-05-08 | -$972.00K derived: sum of 2 quarters · filed 2025-05-08 | $676.00K derived: sum of 3 quarters · filed 2025-05-08 | $461.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.36M derived: sum of 2 quarters · filed 2025-03-11 | $1.15M derived: sum of 3 quarters · filed 2025-03-11 | $641.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.43M derived: sum of 2 quarters · filed 2024-11-06 | $924.00K 10-Q · filed 2024-11-06 | $620.70K 10-Q · filed 2023-11-08 | $635.80K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$724.00K 10-Q · filed 2024-08-06 | -$896.90K 10-Q · filed 2023-08-09 | -$1.01M derived: sum of 3 quarters · filed 2024-08-06 | $951.80K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$509.00K 10-Q · filed 2024-05-07 | -$548.20K 10-Q · filed 2023-05-10 | -$797.20K derived: sum of 2 quarters · filed 2024-05-07 | $1.17M derived: sum of 3 quarters · filed 2024-05-07 | $288.20K derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$288.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.68M derived: sum of 2 quarters · filed 2024-03-12 | $797.20K derived: sum of 3 quarters · filed 2024-03-12 | -$320.00K 10-K · filed 2024-03-12 | -$528.60K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.09M derived: sum of 2 quarters · filed 2023-11-08 | -$31.80K 10-Q · filed 2023-11-08 | -$266.30K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$878.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.00M 10-Q · filed 2023-08-09 | -$2.23M derived: sum of 3 quarters · filed 2023-08-09 | -$34.10K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$1.12M 10-Q · filed 2023-05-10 | -$1.35M derived: sum of 2 quarters · filed 2023-05-10 | $844.50K derived: sum of 3 quarters · filed 2023-05-10 | |||||
| 2021-12-31 | -$234.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $1.96M derived: sum of 2 quarters · filed 2023-03-15 | $2.30M 10-K · filed 2023-03-15 | |||||
| 2021-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.54M 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | $342.70K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |